Copia Wealth Management 10x Genomics, Inc. Transaction History
Copia Wealth Management
- $135 Billion
- Q3 2025
A detailed history of Copia Wealth Management transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Copia Wealth Management holds 140 shares of TXG stock, worth $1,870. This represents 0.0% of its overall portfolio holdings.
Number of Shares
140Holding current value
$1,870% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TXG
# of Institutions
340Shares Held
116MCall Options Held
442KPut Options Held
149K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13.9MShares$186 Million1.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$166 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$85.4 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.01MShares$80.3 Million0.74% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.5.38MShares$71.9 Million0.04% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.27B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...